Angiotensin‐converting enzyme inhibitor (ACEi)‐ or angiotensin receptor blocker (ARB)‐induced angioedema is a rare adverse drug reaction (ADR) resulting in a potentially life‐threatening subcutaneous swelling of, for example, the face, larynx or pharynx.1, 2. The gene discussed is ACE; the disease is angioedema.